The Cardiac Arrhythmia Suppression Trial (CAST) Investigators.Preliminary report: effect of encainide and flecainide on mortality in a randomized trial on arrhythmia suppression after myocardial infarction.N Engl J Med1989; 321: 406–12.
2.
FogorosR.N., FiedlerS.B., ElsonJ.L.Empiric amiodarone versus “ineffective” drug therapy in patients with refractory ventricular tachyarrhythmias.PACE1988; 11: 1009–17.
3.
MirowskiM., MowerM.M., StaewenW.S., TabotznikB., MendeloffA.I.Standby automatic defibrillator: an approach to prevention of sudden coronary death.Arch Intern Med1970; 126: 158–61.
4.
MirowskiM., ReidP.R., MowerM.M.Clinical performance of the implantable cardioverter-defibrillator.PACE1984; 7: 1345–50.
5.
WatkinsLJr., MirowskiM., MowerM.M.Automatic defibrillation in man: the initial surgical experience.J Thorac Cardiovasc Surg1981; 82: 492–500.
6.
WinkleR.A., ThomasA.The automatic implantable cardioverter defibrillator: the U.S. experience. In: BrugadaP., WellensH.J.J., eds. Cardiac arrhythmias: where to go from here?Mount Kisco, New York: Futura Publishing Company, 1987; 663–80.
7.
FranciosaJ.A., WilenM., ZiescheS., CohnJ.N.Survival in men with severe chronic left ventricular failure due to either coronary heart disease or idiopathic dilated cardiomyopathy.Am J Cardiol1983; 51: 831–6.
8.
BiggerJRJr., FleissJ.L., KleigerR., MillerJ.P.Rolnitzky and The Multicenter Post-Infarction Research Group: The relationships among ventricular arrhythmias, left ventricular dysfunction and mortality in the two years after myocardial infarction.Circulation1984; 69: 250–8.
9.
HolmesJ., KuboS.H., CodyR.J., KligfieldP.Arrhythmias in ischemic and nonischemic dilated cardiomyopathy: prediction of mortality by ambulatory electrocardiography.Am J Cardiol1985; 55: 146–51.
10.
HainesD.E., LermanB.B., KronI.L., DiMarcoJ.P.Surgical ablation of ventricular tachycardia with sequential map-guided subendocardial resection: electrophysiologic assessment and long-term follow-up.Circulation1988; 77: 131–41.
11.
GuiraudonG.M.Cryoablation, a versatile tool in arrhythmia surgery.Ann Thorac Surg1987; 43: 129–30.
12.
FontaineG., TonetJ.L., FrankR.Electrode catheter ablation of resistant ventricular tachycardia by endoca-vitary fulguration associated with antiarrhythmic therapy: experience of 38 patients with a mean follow up of 23 months. In: BrugadaP., WellensH.J.J., eds. Cardiac arrhythmias: where to go from here?Mount Kisco, New York: Futura Publishing Company1987; 539–69
13.
WinkleR.A., StinsonE.B., BachSMJr.Measurement of cardioversion/defibrillation thresholds in man by a truncated exponential waveform and an apical patch-superior vena caval spring electrode configuration.Circulation1984; 69: 766–71.
14.
MirowskiM.The automatic implantable cardioverter-defibrillator: an overview.J Am Coll Cardiol1985; 6: 461–6.
WinkleR.A., MeadR.H., RuderM.A.Long-term outcome with the automatic implantable cardioverter-defibrillator.J Am Coll Cardiol1989; 13: 1353–61.
17.
FogorosR.N., ElsonJ.J., BonnetC.A., FiedlerS.B., BurkholderJ.A.Efficacy of the automatic implantable cardioverter-defibrillator in prolonging survival in patients with severe underlying cardiac disease.J Am Coll Cardiol1990; 16: 381–6.
18.
KellyP.A., CannomD.S., GaranH.The automatic implantable cardioverter-defibrillator: efficacy complications and survival in patients with malignant ventricular arrhythmias.J Am Coll Cardiol1988; 11: 1278–86.
19.
KuppermannM., LuceB.R., McGovernB., PodridP.J., BiggerJTJr., RuskinJ.N.An analysis of the cost effectiveness of the implantable defibrillator.Circulation1990; 81: 91–100.
20.
SaksenaS.Clinical progress in endocardial defibrillation.Clin Cardiol1989; 12: 709–14.
